Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0001193125-26-288752
Filing Date
2026-06-29
Accepted
2026-06-29 17:22:27
Documents
3
Period of Report
2026-06-29

Document Format Files

Seq Description Document Type Size
1 6-K d110874d6k.htm 6-K 90486
2 EX-99.1 d110874dex991.htm EX-99.1 60128
3 GRAPHIC g110874abivax.jpg GRAPHIC 6676
  Complete submission text file 0001193125-26-288752.txt   161011
Mailing Address 7 BD HAUSSMANN PARIS France
Business Address 7 BD HAUSSMANN PARIS France 01 53 83 09 63
Abivax S.A. (Filer) CIK: 0001956827 (see all company filings)

EIN.: 000000000 | State of Incorp.: I0 | Fiscal Year End: 1231
Type: 6-K | Act: 34 | File No.: 001-41842 | Film No.: 261136997
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)